Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM1: Emergency Use Authorization of Remdesivir for Patients With Confirmed or Suspected COVID-19

Source: COVID-19 Comprehensive Resource Center
In this concise presentation, Dr. Vikramjit Mukherjee discusses the indications, dosing guidelines, and special considerations outlined in the FDA emergency use authorization of remdesivir for treatment of COVID-19.
Vikramjit Mukherjee, MD
Released: May 22, 2020

Information on this Educational Activity

Faculty

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Vikramjit Mukherjee, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Expert faculty discuss guideline recommendations for nontuberculous mycobacterial lung disease (NTM-LD), from Clinical Care Options (CCO)

Keira A. Cohen, MD
Program Director person default David E. Griffith, MD Princy N. Kumar, MD, FIDSA, MACP Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 19, 2021 Expired: November 18, 2022
Emergence of New Guidelines: NTM Lung Disease in 2021
How can we reduce the time to diagnosis of NTM-LD and linkage to care?
How do you decide to start (or not start) treatment for NTM-LD?
What do you monitor for and how often during NTM-LD treatment?
How do you approach treatment-refractory NTM-LD?

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021

Expert selected highlights of guideline updates for nontuberculous mycobacterial lung disease (NTM-LD), from Clinical Care Options (CCO)

Keira A. Cohen, MD
Program Director person default David E. Griffith, MD Princy N. Kumar, MD, FIDSA, MACP Released: November 8, 2021
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue